Skip to main content
AmigoFish

🧬 Venture Studio Model: Building the Future of AI Drug Discovery | Mati Gill (3/4)

From The Biotech Startups Podcast · · 47 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science.

As a TBSP listener, you can get exclusive perks through Excedr's partner network—special savings, promotions, and more. Explore these offers today: https://www.excedr.com/partners.

"I said we're not signing the investment agreement until you either commit or identify a top employee that speaks the language of the customers that you're going to innovate for."

Jon Chee sits down with Mati Gill, CEO of AION Labs — an Israeli venture studio backed by AstraZeneca, Merck, Pfizer, Teva, AWS, and the Israel Biotech Fund. Mati breaks down how AION Labs builds AI-native pharma companies from the ground up: industry-grade problem statements, multidisciplinary teams, and pharma partner POC commitments locked in before a startup is formed.

Key Topics Covered:

- Israel's Bio-Convergence Policy: How the IIA identified a market failure and built the incentive structure behind AION Labs.

- Venture Studio vs. Traditional VC: Why AION Labs builds deal flow systematically and why pharma R&D expert time outweighs capital.

- Problem Statement Discipline: What makes a challenge worth building a company around, and why POC commitment must come first.

- Multidisciplinary Teams: The lesson from AION Labs' first shutdown — cross-disciplinary hiring is required before any investment closes.

- Operational Infrastructure First: How pre-approved MSAs and a shared AWS cloud give startups pharma data access on day one, not year two.

- Platform vs. Single Asset: Why AION Labs only backs platform technologies and how Insitro's Combinable acquisition proves it.

If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.

Subscribe to the Podcast:

Apple: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994

Spotify: https://open.spotify.com/show/2PSL162R2s0zOwU5913Zv4

YouTube: https://www.youtube.com/@thebiotechstartupspodcast

Website: https://www.thebiotechstartupspodcast.com/?utm_source=podcast&utm_medium=show-notes&utm_campaign=the-biotech-startups-podcast-ep252

Find our guest, Mati Gill, at these links:

LinkedIn: https://www.linkedin.com/in/matigill/?originalSubdomain=il

Website: https://aionlabs.com/

Find our host, Jon Chee, at these links:

LinkedIn: https://www.linkedin.com/in/jonchee/

Learn more about Excedr:

LinkedIn: https://www.linkedin.com/company/excedr/

Website: https://www.excedr.com

Intro & Outro Songs Created by OkKyojin, Owned by Excedr:

Website: https://flow.page/kyojin

Resources & Articles:

AION Labs — Wikipedia Overview: https://en.wikipedia.org/wiki/AION_Labs

Israel's Bio-Convergence Strategy: https://innovationisrael.org.il/en/article/bio-convergence-israels-next-growth-engine/

Hatch-Waxman Act Overview: https://phrma.org/blog/40-years-of-hatch-waxman-what-is-the-hatch-waxman-act

How Biotech Partnerships Support R&D: https://www.excedr.com/blog/how-biotech-partnerships-support-research

PhaseV Raises $50M for AI Clinical Trials: https://www.mobihealthnews.com/news/phasev-scores-50m-ai-clinical-trial-platform

What Corporate Investors Look for in Life Sciences Startups: https://www.excedr.com/blog/what-corporate-investors-look-for-in-life-sciences-startups

Companies, Universities, & People Mentioned:

AION Labs: https://aionlabs.com/

Teva Pharmaceuticals: https://www.tevapharm.com/

Weizmann Institute of Science: https://www.weizmann.ac.il/pages/

BioMed X Institute: https://bmedx.com/

Israel Innovation Authority: https://innovationisrael.org.il/en/

Pfizer: https://www.pfizer.com/

AstraZeneca: https://www.astrazeneca.com/

Merck (Germany): https://www.merckgroup.com/

Amazon Web Services: https://aws.amazon.com/

Israel Biotech Fund: https://ibf.fund/

aMoon:…

Back to The Biotech Startups Podcast · Report a problem